| |
 |
 |
1. Correlation of low numbers of intratumoral FOXP3+ cells with worse progression-free survival in angioimmunoblastic T cell lymphoma.
Liu HL, Weng SW, Chou CC, You HL, Wang MC, Ma MC, Huang WT.
J Clin Pathol. 2023 Aug 24:jcp-2023-208932. doi: 10.1136/jcp-2023-208932. Online ahead of print.PMID: 37620127
2. Combination of Sarcopenia and Anemia Predicts Worse Outcome in
Elderly Patients With Diffuse Large B-Cell Lymphoma.
Liao PH, Chuang YH, Yang FS, Kuo CY, Ma MC, Liao CK, Wang MC.
In Vivo. 2023 Jul-Aug;37(4):1847-1856. doi: 10.21873/invivo.13276.PMID: 37369473Free PMC article.
3. Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR-Mutated MPN.
Wang YH, Chen YJ, Lai YH, Wang MC, Chen YY, Wu YY, Yang YR, Tsou HY, Li CP, Hsu CC, Huang CE, Chen CC.
Int J Mol Sci. 2023 May 14;24(10):8747. doi: 10.3390/ijms24108747.PMID: 37240094Free PMC article.
4. Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.
Liu HC, Kuo MC, Wu KH, Chen TY, Chen JS, Wang MC, Lin TL, Yang Y, Ma MC, Wang PN, Sheen JM, Wang SC, Chen SH, Jaing TH, Cheng CN, Yeh TC, Lin TH, Shih LY.
Br J Cancer. 2023 Mar;128(7):1294-1300. doi: 10.1038/s41416-023-02162-9. Epub 2023 Jan 30.PMID: 36717672
5. Flow Cytometry Analysis Reveals a Wide Cytologic and Immunophenotypic Spectrum of Peripheral B Lymphocytes in Angioimmunoblastic T-Cell Lymphoma.
Liu HL, Liao CK, Weng SW, Shih LY, Chou CC, You HL, Wang MC, Huang WT.
Pathobiology. 2023;90(3):187-198. doi: 10.1159/000526284. Epub 2022 Nov 24.PMID: 36423589
6. Oral Chemotherapy Application in Elderly Patients With Diffuse Large B-Cell Lymphoma: An Alternative Regimen in Retrospective Analysis.
Liao PH, Kuo CY, Ma MC, Liao CK, Pei SN, Wang MC.
J Hematol. 2022 Oct;11(5):176-184. doi: 10.14740/jh1054. Epub 2022 Oct 31.PMID: 36406829Free PMC article.
7. Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia.
Su YJ, Kuo MC, Chen TY, Wang MC, Yang Y, Ma MC, Lin TL, Lin TH, Chang H, Teng CJ, Hsiao PC, Chen CC, Wang PN, Shih LY.
Cancer Sci. 2022 Oct;113(10):3518-3527. doi: 10.1111/cas.15501. Epub 2022 Aug 17.PMID: 35869805Free PMC article.
8. Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.
Sunami K, Ikeda T, Huang SY, Wang MC, Koh Y, Min CK, Yeh SP, Matsumoto M, Uchiyama M, Iyama S, Shimazaki C, Lee JH, Kim K, Kaneko H, Kim JS, Lin TL, Campana F, Tada K, Iida S, Suzuki K; ICARIA-MM study group.
Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):e751-e761. doi: 10.1016/j.clml.2022.04.005. Epub 2022 Apr 8.PMID: 35641409
9. Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data.
Su YC, Chiu BC, Li HJ, Yang WC, Chen TY, Yeh SP, Wang MC, Huang WT, Lee MY, Lin SF.
PLoS One. 2022 Mar 17;17(3):e0265543. doi: 10.1371/journal.pone.0265543. eCollection 2022.PMID: 35298555Free PMC article.
10. The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan.
Du JS, Kuo YC, Shi HY, Wang MC, Wang LY, Chuang TM, Ke YL, Yeh TJ, Gau YC, Wang HC, Cho SF, Hsiao SY, Liu YC, Hsu CM, Hsiao HH.
J Pers Med. 2022 Jan 19;12(2):130. doi: 10.3390/jpm12020130.PMID: 35207619Free PMC article.
11.Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial.
Roboz GJ, Döhner H, Pocock C, Dombret H, Ravandi F, Jang JH, Selleslag D, Mayer J, Martens UM, Liesveld J, Bernal T, Wang MC, Yu P, Shi L, Guo S, La Torre I, Skikne B, Dong Q, Braverman J, Nehme SA, Beach CL, Wei AH.
Haematologica. 2021 Dec 1;106(12):3240-3244. doi: 10.3324/haematol.2021.279174.PMID: 34551506Free PMC article.Clinical Trial.No abstract available.
12. Role of quantitative hepatitis B surface antibodies in preventing hepatitis B virus-related hepatitis in patients treated with rituximab.
Pei SN, Liu YF, Kuo CY, Wang MC, Ma MC, Liao CK, Ng HY, Chen CH.
Leuk Lymphoma. 2021 Dec;62(12):2899-2906. doi: 10.1080/10428194.2021.1948034. Epub 2021 Jul 29.PMID: 34323157
13. Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics.
Harrison SJ, Perrot A, Alegre A, Simpson D, Wang MC, Spencer A, Delimpasi S, Hulin C, Sunami K, Facon T, Vlummens P, Yong K, Campana F, Inchauspé M, Macé S, Risse ML, van de Velde H, Richardson P.
Br J Haematol. 2021 Jul;194(1):120-131. doi: 10.1111/bjh.17499. Epub 2021 May 25.PMID: 34036560Free PMC article.
14. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
Pei SN, Wang MC, Ma MC, Kuo CY, Liao CK, Qiu H, Rothwell LA, Liu Y.
Sci Rep. 2021 May 12;11(1):10069. doi: 10.1038/s41598-021-89316-y.PMID: 33980914Free PMC article.
15. Differential impacts of hemolysis on coagulation parameters of blood samples: A STROBE-compliant article.
Pan LL, Lee CH, Hung KC, Tsai IT, Wang MC, Sun CK.
Medicine (Baltimore). 2021 May 7;100(18):e25798. doi: 10.1097/MD.0000000000025798.PMID: 33950978Free PMC article.
16. Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.
Matasar MJ, Capra M, Özcan M, Lv F, Li W, Yañez E, Sapunarova K, Lin T, Jin J, Jurczak W, Hamed A, Wang MC, Baker R, Bondarenko I, Zhang Q, Feng J, Geissler K, Lazaroiu M, Saydam G, Szomor Á, Bouabdallah K, Galiulin R, Uchida T, Soler LM, Cao A, Hiemeyer F, Mehra A, Childs BH, Shi Y, Zinzani PL.
Lancet Oncol. 2021 May;22(5):678-689. doi: 10.1016/S1470-2045(21)00145-5. Epub 2021 Apr 10.PMID: 33848462Clinical Trial.
17. The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma.
Lu SY, Ma MC, Wang MC, Hsue SS.
J Formos Med Assoc. 2021 Nov;120(11):1967-1976. doi: 10.1016/j.jfma.2021.01.015. Epub 2021 Feb 4.PMID: 33551311
18. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
Chou CC, Tsao CF, Liao CK, You HL, Wang MC, Huang WT.
Exp Mol Pathol. 2021 Feb;118:104577. doi: 10.1016/j.yexmp.2020.104577. Epub 2020 Nov 23.PMID: 33242451
19. Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia.
Fujishima N, Uchida T, Onishi Y, Jung CW, Goh YT, Ando K, Wang MC, Ono C, Matsumizu M, Paccagnella ML, Sleight B, Vandendries E, Fujii Y, Hino M.
Int J Hematol. 2019 Dec;110(6):709-722. doi: 10.1007/s12185-019-02749-0. Epub 2019 Nov 13.PMID: 31655984Clinical Trial.
20. Molecular heterogeneity unravelled by single-cell transcriptomics in patients with essential thrombocythaemia.
Hsu CC, Chen YJ, Huang CE, Wu YY, Wang MC, Pei SN, Liao CK, Lu CH, Chen PT, Tsou HY, Li CP, Chuang WH, Chuang CK, Yang CY, Lai YH, Lin YH, Chen CC.
Br J Haematol. 2020 Mar;188(5):707-722. doi: 10.1111/bjh.16225. Epub 2019 Oct 14.PMID: 31610612Clinical Trial.
21. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
Lee PH, Weng SW, Liu TT, You HL, Liao CK, Wang MC, Huang WT.
Exp Mol Pathol. 2019 Oct;110:104294. doi: 10.1016/j.yexmp.2019.104294. Epub 2019 Aug 5.PMID: 31394087
22. Recurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression: An implication for anti-CD20 (rituximab) antibody therapy?
Liao PH, Chou SC, Huang WT, Su YZ, Wang MC, Chuang SS.
Pathol Int. 2018 Dec;68(12):712-714. doi: 10.1111/pin.12730. Epub 2018 Nov 6.PMID: 30402988No abstract available.
23.Impacts of demographic and laboratory parameters on key hematological indices in an adult population of southern Taiwan: A cohort study.
Wang MC, Huang CE, Lin MH, Yang YH, Lu CH, Chen PT, Wu YY, Tsou HY, Hsu CC, Chen CC.
PLoS One. 2018 Aug 2;13(8):e0201708. doi: 10.1371/journal.pone.0201708. eCollection 2018.PMID: 30071080Free PMC article.
24. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression.
Huang HS, Liao CK, Liu TT, You HL, Wang MC, Huang WT.
Hum Pathol. 2018 Oct;80:145-151. doi: 10.1016/j.humpath.2018.05.026. Epub 2018 Jun 6.PMID: 29885407
25. A Newly Recognized Histologic Pattern of IgG4-related Lymphadenopathy: Expanding the Morphologic Spectrum.
Chen YR, Chen YJ, Wang MC, Medeiros LJ, Chang KC.
Am J Surg Pathol. 2018 Jul;42(7):977-982. doi: 10.1097/PAS.0000000000001076.PMID: 29738364
26. A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients.
Tsai HJ, Jiang SS, Hung WC, Borthakur G, Lin SF, Pemmaraju N, Jabbour E, Bomalaski JS, Chen YP, Hsiao HH, Wang MC, Kuo CY, Chang H, Yeh SP, Cortes J, Chen LT, Chen TY.
Sci Rep. 2017 Sep 12;7(1):11253. doi: 10.1038/s41598-017-10542-4.PMID: 28900115Free PMC article.Clinical Trial.
27. A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan.
Huang SY, Yu YB, Yeh SP, Chen TY, Kao WY, Chen CC, Wang MC, Lin HY, Lin SF, Lin TH, Hua Y, Puccio-Pick M, DeMarco D, Jacques C, Dunn P.
J Formos Med Assoc. 2017 Sep;116(9):705-710. doi: 10.1016/j.jfma.2016.11.005. Epub 2016 Dec 21.PMID: 28012677
28. Characteristics of Taiwanese patients of PNH in the international PNH registry.
Chou WC, Huang WH, Wang MC, Chang CS, Yeh SP, Chiou TJ, Chen YC, Lin TH, Shen MC; Taiwan PNH study group.
Thromb J. 2016 Oct 4;14(Suppl 1):39. doi: 10.1186/s12959-016-0094-0. eCollection 2016.PMID: 27766064Free PMC article.
29. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy.
Liu TT, Weng SW, Wang MC, Huang WT.
APMIS. 2016 Mar;124(3):216-20. doi: 10.1111/apm.12492. Epub 2015 Dec 14.PMID: 26660641
30. Eltrombopag enhances platelet adhesion by upregulating the expression of glycoprotein VI in patients with chronic immune thrombocytopenic purpura.
Chiou TJ, Chang YF, Wang MC, Kao CW, Lin HY, Chen TY, Hsueh EJ, Lan YJ, Sung YC, Lin SF, Bai LY, Chen CG.
Transl Res. 2015 Dec;166(6):750-761.e4. doi: 10.1016/j.trsl.2015.09.005. Epub 2015 Sep 30.PMID: 26477577
31.Genetic disposition and modifiable factors independently associated with anemia in patients with type 2 diabetes mellitus.
Chiou TT, Lee JJ, Wang MC, Chung MS, Pan LL, Hsieh CJ, Huang ST, Chang HW, Yang KD, Lee CT, Liu RT.
Diabetes Res Clin Pract. 2015 Apr;108(1):164-9. doi: 10.1016/j.diabres.2014.12.012. Epub 2015 Jan 21.PMID: 25656761
32. Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis.
Jung CW, Shih LY, Xiao Z, Jie J, Hou HA, Du X, Wang MC, Park S, Eom KS, Oritani K, Okamoto S, Tauchi T, Kim JS, Zhou D, Saito S, Li J, Handa H, Jianyong L, Ohishi K, Hou M, Depei W, Takenaka K, Liu T, Hu Y, Amagasaki T, Ito K, Gopalakrishna P, Akashi K.
Leuk Lymphoma. 2015 Jul;56(7):2067-74. doi: 10.3109/10428194.2014.969260. Epub 2014 Nov 20.PMID: 25315076Clinical Trial.
33. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.
San-Miguel JF, Hungria VT, Yoon SS, Beksac M, Dimopoulos MA, Elghandour A, Jedrzejczak WW, Günther A, Nakorn TN, Siritanaratkul N, Corradini P, Chuncharunee S, Lee JJ, Schlossman RL, Shelekhova T, Yong K, Tan D, Numbenjapon T, Cavenagh JD, Hou J, LeBlanc R, Nahi H, Qiu L, Salwender H, Pulini S, Moreau P, Warzocha K, White D, Bladé J, Chen W, de la Rubia J, Gimsing P, Lonial S, Kaufman JL, Ocio EM, Veskovski L, Sohn SK, Wang MC, Lee JH, Einsele H, Sopala M, Corrado C, Bengoudifa BR, Binlich F, Richardson PG.
Lancet Oncol. 2014 Oct;15(11):1195-206. doi: 10.1016/S1470-2045(14)70440-1. Epub 2014 Sep 18.PMID: 25242045Clinical Trial.
34. Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Hsiao LT, Tien HF, Kuo CY, Wu JH, Hou HA, Wang MC, Liu CY, Chen PM, Chiou TJ.
Hematol Oncol. 2015 Dec;33(4):136-44. doi: 10.1002/hon.2161. Epub 2014 Aug 11.PMID: 25111959Clinical Trial.
35. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC, Chang ST, Hsieh YC, Huang WT, Hsu JD, Tseng CE, Wang MC, Hwang WS, Wang J, Chuang SS.
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2430-7. eCollection 2014.PMID: 24966953Free PMC article.
36. TMPRSS6 rs855791 polymorphism influences the susceptibility to iron deficiency anemia in women at reproductive age.
Pei SN, Ma MC, You HL, Fu HC, Kuo CY, Rau KM, Wang MC, Lee CT.
Int J Med Sci. 2014 Apr 16;11(6):614-9. doi: 10.7150/ijms.8582. eCollection 2014.PMID: 24782651Free PMC article.
37. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.
Hsu C, Tsou HH, Lin SJ, Wang MC, Yao M, Hwang WL, Kao WY, Chiu CF, Lin SF, Lin J, Chang CS, Tien HF, Liu TW, Chen PJ, Cheng AL; Taiwan Cooperative Oncology Group.
Hepatology. 2014 Jun;59(6):2092-100. doi: 10.1002/hep.26718. Epub 2014 Apr 14.PMID: 24002804
38. Infectious mononucleosis mimicking malignant T-cell lymphoma in the nasopharynx: a case report and review of the literature.
He HL, Wang MC, Huang WT.
Int J Clin Exp Pathol. 2013;6(1):105-9. Epub 2012 Nov 20.PMID: 23236550Free PMC article.Review.
39. Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure.
Shih LY, Kuo MC, Kuo CY, Lin TH, Bai LY, Chen TY, Wang MC, Lin TL, Lan YJ, Chen CC, Yang Y, Hsiao PC, Lai CL, Chang CH, Lin TH.
Leuk Res. 2013 Jan;37(1):43-9. doi: 10.1016/j.leukres.2012.09.012. Epub 2012 Oct 9.PMID: 23062378
40. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
Pei SN, Ma MC, Wang MC, Kuo CY, Rau KM, Su CY, Chen CH.
Ann Hematol. 2012 Jul;91(7):1007-12. doi: 10.1007/s00277-012-1405-6. Epub 2012 Jan 25.PMID: 22273839
41. Bcr-Abl oncogene stimulates Jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells.
Yang KT, Wang MC, Chen JY, Hsu MC, Hung WC.
J Cell Physiol. 2011 Nov;226(11):2849-56. doi: 10.1002/jcp.22633.PMID: 21935931
42. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells.
Chen JY, Wang MC, Hung WC.
J Cell Physiol. 2011 Feb;226(2):407-13. doi: 10.1002/jcp.22346.PMID: 20717963
43. Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.
Lee CH, Wang MC, Huang IW, Chen FJ, Lauderdale TL.
Antimicrob Agents Chemother. 2010 Sep;54(9):4038-40. doi: 10.1128/AAC.00533-10. Epub 2010 Jun 28.PMID: 20585116Free PMC article.No abstract available.
44. Recurrent capillary leak syndrome following bortezomib therapy in a patient with relapsed myeloma.
Hsiao SC, Wang MC, Chang H, Pei SN.
Ann Pharmacother. 2010 Mar;44(3):587-9. doi: 10.1345/aph.1M585. Epub 2010 Feb 11.PMID: 20150504
45. Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients.
Pei SN, Chen CH, Lee CM, Wang MC, Ma MC, Hu TH, Kuo CY.
Ann Hematol. 2010 Mar;89(3):255-62. doi: 10.1007/s00277-009-0806-7. Epub 2009 Aug 21.PMID: 19697028
46. Transcriptional activation of Skp2 by BCR-ABL in K562 chronic myeloid leukemia cells.
Chen JY, Wang MC, Hung WC.
Leuk Res. 2009 Nov;33(11):1520-4. doi: 10.1016/j.leukres.2009.03.007. Epub 2009 Mar 28.PMID: 19329185
47. Mediastinal mass and malignant pleural effusion in an aleukemic case with pre-B acute lymphoblastic leukemia.
Pei SN, Kuo CY, Ma MC, Wang MC.
J Pediatr Hematol Oncol. 2009 Feb;31(2):139-41. doi: 10.1097/MPH.0b013e31818c2619.PMID: 19194202
48. Hepatosplenic fungal infection in adult patients with acute leukemia.
Ma MC, Wang MC, Pei SN, Kuo CY.
Chang Gung Med J. 2008 Jan-Feb;31(1):74-80.PMID: 18419056
49. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin` lymphoma: a randomized trial.
Hsu C, Hsiung CA, Su IJ, Hwang WS, Wang MC, Lin SF, Lin TH, Hsiao HH, Young JH, Chang MC, Liao YM, Li CC, Wu HB, Tien HF, Chao TY, Liu TW, Cheng AL, Chen PJ.
Hepatology. 2008 Mar;47(3):844-53. doi: 10.1002/hep.22106.PMID: 18302293Clinical Trial.
50. Chronic myeloid leukemia after living donor liver transplantation.
Concejero A, Chen CL, Wang CC, Wang SH, Lin CC, Liu YW, Yang CH, Yong CC, Wang MC, Eng HL.
Transplantation. 2007 Jun 15;83(11):1521-2. doi: 10.1097/01.tp.0000265587.17307.6a.PMID: 17565329No abstract available.
51. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Tsai MS, Kuo CY, Wang MC, Wu HC, Chien CC, Liu JW.
J Microbiol Immunol Infect. 2006 Apr;39(2):150-4.PMID: 16604248
52. Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin` lymphoma.
Liao CA, Lee CM, Wu HC, Wang MC, Lu SN, Eng HL.
Br J Haematol. 2002 Jan;116(1):166-9. doi: 10.1046/j.1365-2141.2002.03239.x.PMID: 11841412
|
|
